Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.32 |
| ▸ | RELA | Q04206 | 4/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | CASP7 | P55210 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | RYR2 | Q92736 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL85928 | 0.90 | THRB (0.37) | KDM4EALDH1A1THRBLMNASMN1; SMN2 | |
| SCHEMBL31260278 | 0.81 | ALDH1A1 (0.57) | KDM4EALDH1A1HTTLMNASMN1; SMN2 | |
| SCHEMBL1987343 | 0.81 | ALDH1A1 (0.57) | KDM4EALDH1A1HTTLMNASMN1; SMN2 | |
| SCHEMBL31260280 | 0.81 | ALDH1A1 (0.57) | KDM4EALDH1A1HTTLMNASMN1; SMN2 | |
| SCHEMBL87292 | 0.72 | ACHE (0.40) | KDM4EALDH1A1HTTTHRBLMNA | |
| SCHEMBL2125101 | 0.70 | THRB (0.45) | KDM4ETHRBNFKB1NFKB2RELA | |
| SCHEMBL15497458 | 0.70 | KDM4E (0.35) | KDM4EALDH1A1HTTLMNAHPGD | |
| SCHEMBL1140756 | 0.69 | ALDH1A1 (0.47) | KDM4EALDH1A1HTTLMNASMN1; SMN2 | |
| SCHEMBL87106 | 0.69 | THRB (0.38) | KDM4EALDH1A1HTTTHRBLMNA | |
| SCHEMBL11225929 | 0.67 | THRB (0.47) | KDM4EALDH1A1THRBSMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2053095-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORP (JP) | 2017-02-22 | — | — | EP | disclosed |
| EP-2053095-B1 | Ink composition and inkjet recording method using the same | FUJIFILM CORP (JP) | 2014-03-26 | — | — | EP | disclosed |
| US-8129447-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8129447-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| EP-2053095-A2 | Ink composition and inkjet recording method using the same | Fujifilm Corporation (JP) | 2009-04-29 | — | — | EP | disclosed |
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | RB1, IK, NOX1 | KDM4E 679/4885ALDH1A1 440/4885HTT 3488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.